Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Cannabidiol CR
DRUG
2 trials
Sponsors
Central Institute of Mental Health, Mannheim
Conditions
Schizophrenia
Phase 1
Evaluation Study of New Compounds With Potential Use in Schizophrenia
Withdrawn
NCT00916201
Central Institute of Mental Health, Mannheim
Schizophrenia
Start: 2025-01-31
End: 2025-01-31
Updated: 2025-03-21
Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study
Completed
NCT02051387
Central Institute of Mental Health, Mannheim
Schizophrenia
Start: 2013-01-31
End: 2017-08-31
Updated: 2018-03-08